Overall survival from randomization of all eligible and evaluable patients in three risk groups according to initial LDH, unfavorable karyotype, and day-16 bone marrow blasts. “Other patients” include the rest of the patients whose risk is not defined by the criteria listed above. Tick marks indicate patients alive and patients censored at the time of allogeneic bone marrow tranplantation.